The effect of providing fansidar (sulfadoxine-pyrimethamine) in schools on mortality in school-age children in Malawi

Malaria is a major cause of death in school-age (5–18 years) children in Malawi. Save the Children Federation helped schools in Mangochi District, Malawi, to obtain pupil-treatment kits, which enabled teachers to dispense sulfadoxine-pyrimethamine tablets according to national guidelines. The overal...

Full description

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 2003-02, Vol.361 (9357), p.577-578
Main Authors: Pasha, Omrana, Rosso, Joy Del, Mukaka, Mary, Marsh, David
Format: Article
Language:English
Subjects:
Adolescent
Antimalarials - therapeutic use
Biological and medical sciences
Child
Children & youth
Drug Combinations
Health care
Human protozoal diseases
Humans
Infectious diseases
Malaria
Malaria - drug therapy
Malaria - epidemiology
Malaria - mortality
Malawi - epidemiology
Medical sciences
Mortality
Parasitic diseases
Pharmaceuticals
Protozoal diseases
Pyrimethamine - therapeutic use
Schools
Students
Sulfadoxine - therapeutic use
Tropical medicine
Vector-borne diseases
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c418t-e35cae6ab9baa2ad2f02f04cb61351f919f856822a4df8d800b93e719691d24b3
cites cdi_FETCH-LOGICAL-c418t-e35cae6ab9baa2ad2f02f04cb61351f919f856822a4df8d800b93e719691d24b3
container_end_page 578
container_issue 9357
container_start_page 577
container_title The Lancet (British edition)
container_volume 361
creator Pasha, Omrana
Rosso, Joy Del
Mukaka, Mary
Marsh, David
description Malaria is a major cause of death in school-age (5–18 years) children in Malawi. Save the Children Federation helped schools in Mangochi District, Malawi, to obtain pupil-treatment kits, which enabled teachers to dispense sulfadoxine-pyrimethamine tablets according to national guidelines. The overall and malaria-specific mortality rates were calculated for the 3 years before and 2 years after the intervention was introduced; rates dropped from 2·2 to 1·44 deaths/1000 student-years and from 1·28 to 0·44 deaths/1000 student-years, respectively. School-based interventions could play a part in mitigating malaria.
doi_str_mv 10.1016/S0140-6736(03)12511-1
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73038534</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0140673603125111</els_id><sourcerecordid>73038534</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-e35cae6ab9baa2ad2f02f04cb61351f919f856822a4df8d800b93e719691d24b3</originalsourceid><addsrcrecordid>eNqFkV1rFDEUhoModl39CUoQLO3FaDL5mMmVSPELKl5YwbuQSU66KbPJNpmp3X9vtru44I0QCDk853DyPgi9pOQtJVS--0EoJ43smDwj7Jy2gtKGPkILyjveCN79eowWf5ET9KyUG0IIl0Q8RScVVz3lcoHmqxVg8B7shJPHm5zuggvxGnsTS3Am47Myj964dB8iNJttDmuYVmZdX-c4RFzsKqWx4BTxOuXJjGHaHuuNuQZsV2F0GeKu_M2M5nd4jp54MxZ4cbiX6Oenj1cXX5rL75-_Xny4bCyn_dQAE9aANIMajGmNaz2ph9tBUiaoV1T5Xsi-bQ13vnc9IYNi0FElFXUtH9gSne7n1n_dzlAmvQ7FwjiaCGkuumOE9YLxCr7-B7xJc451N02VIq3sK7lEYg_ZnErJ4PWmpmHyVlOid1L0gxS9S1wTph-kaFr7Xh2Gz8Ma3LHrYKECbw6AKdaMPptoQzlyXHAlSFe593sOamZ3AbIuNkC04EKuArVL4T-r_AFi76l6</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>199026830</pqid></control><display><type>article</type><title>The effect of providing fansidar (sulfadoxine-pyrimethamine) in schools on mortality in school-age children in Malawi</title><source>Business Source Ultimate</source><source>Elsevier:Jisc Collections:Elsevier Read and Publish Agreement 2022-2024:Freedom Collection (Reading list)</source><creator>Pasha, Omrana ; Rosso, Joy Del ; Mukaka, Mary ; Marsh, David</creator><creatorcontrib>Pasha, Omrana ; Rosso, Joy Del ; Mukaka, Mary ; Marsh, David</creatorcontrib><description>Malaria is a major cause of death in school-age (5–18 years) children in Malawi. Save the Children Federation helped schools in Mangochi District, Malawi, to obtain pupil-treatment kits, which enabled teachers to dispense sulfadoxine-pyrimethamine tablets according to national guidelines. The overall and malaria-specific mortality rates were calculated for the 3 years before and 2 years after the intervention was introduced; rates dropped from 2·2 to 1·44 deaths/1000 student-years and from 1·28 to 0·44 deaths/1000 student-years, respectively. School-based interventions could play a part in mitigating malaria.</description><identifier>ISSN: 0140-6736</identifier><identifier>EISSN: 1474-547X</identifier><identifier>DOI: 10.1016/S0140-6736(03)12511-1</identifier><identifier>PMID: 12598146</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>London: Elsevier Ltd</publisher><subject>Adolescent ; Antimalarials - therapeutic use ; Biological and medical sciences ; Child ; Children &amp; youth ; Drug Combinations ; Health care ; Human protozoal diseases ; Humans ; Infectious diseases ; Malaria ; Malaria - drug therapy ; Malaria - epidemiology ; Malaria - mortality ; Malawi - epidemiology ; Medical sciences ; Mortality ; Parasitic diseases ; Pharmaceuticals ; Protozoal diseases ; Pyrimethamine - therapeutic use ; Schools ; Students ; Sulfadoxine - therapeutic use ; Tropical medicine ; Vector-borne diseases</subject><ispartof>The Lancet (British edition), 2003-02, Vol.361 (9357), p.577-578</ispartof><rights>2003 Elsevier Ltd</rights><rights>2003 INIST-CNRS</rights><rights>Copyright Lancet Ltd. Feb 15, 2003</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-e35cae6ab9baa2ad2f02f04cb61351f919f856822a4df8d800b93e719691d24b3</citedby><cites>FETCH-LOGICAL-c418t-e35cae6ab9baa2ad2f02f04cb61351f919f856822a4df8d800b93e719691d24b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14549507$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12598146$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pasha, Omrana</creatorcontrib><creatorcontrib>Rosso, Joy Del</creatorcontrib><creatorcontrib>Mukaka, Mary</creatorcontrib><creatorcontrib>Marsh, David</creatorcontrib><title>The effect of providing fansidar (sulfadoxine-pyrimethamine) in schools on mortality in school-age children in Malawi</title><title>The Lancet (British edition)</title><addtitle>Lancet</addtitle><description>Malaria is a major cause of death in school-age (5–18 years) children in Malawi. Save the Children Federation helped schools in Mangochi District, Malawi, to obtain pupil-treatment kits, which enabled teachers to dispense sulfadoxine-pyrimethamine tablets according to national guidelines. The overall and malaria-specific mortality rates were calculated for the 3 years before and 2 years after the intervention was introduced; rates dropped from 2·2 to 1·44 deaths/1000 student-years and from 1·28 to 0·44 deaths/1000 student-years, respectively. School-based interventions could play a part in mitigating malaria.</description><subject>Adolescent</subject><subject>Antimalarials - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Children &amp; youth</subject><subject>Drug Combinations</subject><subject>Health care</subject><subject>Human protozoal diseases</subject><subject>Humans</subject><subject>Infectious diseases</subject><subject>Malaria</subject><subject>Malaria - drug therapy</subject><subject>Malaria - epidemiology</subject><subject>Malaria - mortality</subject><subject>Malawi - epidemiology</subject><subject>Medical sciences</subject><subject>Mortality</subject><subject>Parasitic diseases</subject><subject>Pharmaceuticals</subject><subject>Protozoal diseases</subject><subject>Pyrimethamine - therapeutic use</subject><subject>Schools</subject><subject>Students</subject><subject>Sulfadoxine - therapeutic use</subject><subject>Tropical medicine</subject><subject>Vector-borne diseases</subject><issn>0140-6736</issn><issn>1474-547X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqFkV1rFDEUhoModl39CUoQLO3FaDL5mMmVSPELKl5YwbuQSU66KbPJNpmp3X9vtru44I0QCDk853DyPgi9pOQtJVS--0EoJ43smDwj7Jy2gtKGPkILyjveCN79eowWf5ET9KyUG0IIl0Q8RScVVz3lcoHmqxVg8B7shJPHm5zuggvxGnsTS3Am47Myj964dB8iNJttDmuYVmZdX-c4RFzsKqWx4BTxOuXJjGHaHuuNuQZsV2F0GeKu_M2M5nd4jp54MxZ4cbiX6Oenj1cXX5rL75-_Xny4bCyn_dQAE9aANIMajGmNaz2ph9tBUiaoV1T5Xsi-bQ13vnc9IYNi0FElFXUtH9gSne7n1n_dzlAmvQ7FwjiaCGkuumOE9YLxCr7-B7xJc451N02VIq3sK7lEYg_ZnErJ4PWmpmHyVlOid1L0gxS9S1wTph-kaFr7Xh2Gz8Ma3LHrYKECbw6AKdaMPptoQzlyXHAlSFe593sOamZ3AbIuNkC04EKuArVL4T-r_AFi76l6</recordid><startdate>20030215</startdate><enddate>20030215</enddate><creator>Pasha, Omrana</creator><creator>Rosso, Joy Del</creator><creator>Mukaka, Mary</creator><creator>Marsh, David</creator><general>Elsevier Ltd</general><general>Lancet</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TT</scope><scope>0TZ</scope><scope>0U~</scope><scope>3V.</scope><scope>7QL</scope><scope>7QP</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88C</scope><scope>88E</scope><scope>88G</scope><scope>88I</scope><scope>8AF</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AN0</scope><scope>ASE</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FPQ</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K6X</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KB~</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>S0X</scope><scope>7X8</scope></search><sort><creationdate>20030215</creationdate><title>The effect of providing fansidar (sulfadoxine-pyrimethamine) in schools on mortality in school-age children in Malawi</title><author>Pasha, Omrana ; Rosso, Joy Del ; Mukaka, Mary ; Marsh, David</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-e35cae6ab9baa2ad2f02f04cb61351f919f856822a4df8d800b93e719691d24b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Adolescent</topic><topic>Antimalarials - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Children &amp; youth</topic><topic>Drug Combinations</topic><topic>Health care</topic><topic>Human protozoal diseases</topic><topic>Humans</topic><topic>Infectious diseases</topic><topic>Malaria</topic><topic>Malaria - drug therapy</topic><topic>Malaria - epidemiology</topic><topic>Malaria - mortality</topic><topic>Malawi - epidemiology</topic><topic>Medical sciences</topic><topic>Mortality</topic><topic>Parasitic diseases</topic><topic>Pharmaceuticals</topic><topic>Protozoal diseases</topic><topic>Pyrimethamine - therapeutic use</topic><topic>Schools</topic><topic>Students</topic><topic>Sulfadoxine - therapeutic use</topic><topic>Tropical medicine</topic><topic>Vector-borne diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pasha, Omrana</creatorcontrib><creatorcontrib>Rosso, Joy Del</creatorcontrib><creatorcontrib>Mukaka, Mary</creatorcontrib><creatorcontrib>Marsh, David</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>News PRO</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Global News &amp; ABI/Inform Professional</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Proquest Nursing &amp; Allied Health Source</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>British Nursing Index</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>British Nursing Index</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Newsstand Professional</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet (British edition)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pasha, Omrana</au><au>Rosso, Joy Del</au><au>Mukaka, Mary</au><au>Marsh, David</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effect of providing fansidar (sulfadoxine-pyrimethamine) in schools on mortality in school-age children in Malawi</atitle><jtitle>The Lancet (British edition)</jtitle><addtitle>Lancet</addtitle><date>2003-02-15</date><risdate>2003</risdate><volume>361</volume><issue>9357</issue><spage>577</spage><epage>578</epage><pages>577-578</pages><issn>0140-6736</issn><eissn>1474-547X</eissn><coden>LANCAO</coden><abstract>Malaria is a major cause of death in school-age (5–18 years) children in Malawi. Save the Children Federation helped schools in Mangochi District, Malawi, to obtain pupil-treatment kits, which enabled teachers to dispense sulfadoxine-pyrimethamine tablets according to national guidelines. The overall and malaria-specific mortality rates were calculated for the 3 years before and 2 years after the intervention was introduced; rates dropped from 2·2 to 1·44 deaths/1000 student-years and from 1·28 to 0·44 deaths/1000 student-years, respectively. School-based interventions could play a part in mitigating malaria.</abstract><cop>London</cop><pub>Elsevier Ltd</pub><pmid>12598146</pmid><doi>10.1016/S0140-6736(03)12511-1</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0140-6736
ispartof The Lancet (British edition), 2003-02, Vol.361 (9357), p.577-578
issn 0140-6736
1474-547X
language eng
recordid cdi_proquest_miscellaneous_73038534
source Business Source Ultimate; Elsevier:Jisc Collections:Elsevier Read and Publish Agreement 2022-2024:Freedom Collection (Reading list)
subjects Adolescent
Antimalarials - therapeutic use
Biological and medical sciences
Child
Children & youth
Drug Combinations
Health care
Human protozoal diseases
Humans
Infectious diseases
Malaria
Malaria - drug therapy
Malaria - epidemiology
Malaria - mortality
Malawi - epidemiology
Medical sciences
Mortality
Parasitic diseases
Pharmaceuticals
Protozoal diseases
Pyrimethamine - therapeutic use
Schools
Students
Sulfadoxine - therapeutic use
Tropical medicine
Vector-borne diseases
title The effect of providing fansidar (sulfadoxine-pyrimethamine) in schools on mortality in school-age children in Malawi
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T03%3A16%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effect%20of%20providing%20fansidar%20(sulfadoxine-pyrimethamine)%20in%20schools%20on%20mortality%20in%20school-age%20children%20in%20Malawi&rft.jtitle=The%20Lancet%20(British%20edition)&rft.au=Pasha,%20Omrana&rft.date=2003-02-15&rft.volume=361&rft.issue=9357&rft.spage=577&rft.epage=578&rft.pages=577-578&rft.issn=0140-6736&rft.eissn=1474-547X&rft.coden=LANCAO&rft_id=info:doi/10.1016/S0140-6736(03)12511-1&rft_dat=%3Cproquest_cross%3E73038534%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c418t-e35cae6ab9baa2ad2f02f04cb61351f919f856822a4df8d800b93e719691d24b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=199026830&rft_id=info:pmid/12598146&rfr_iscdi=true